Literature DB >> 19174186

Atypical pathways of NF-kappaB activation and aging.

Andres Kriete1, Kelli L Mayo.   

Abstract

The eukaryotic transcription factor Nuclear Factor-kappaB (NF-kappaB) is a master regulator for inflammatory responses, mediating cellular defense against infectious agents and environmental and cellular stress. However, recent evidence-based studies have demonstrated that constitutive activation of NF-kappaB is a ubiquitous phenomenon among various cell types in the aging phenotype, contributing deleterious effects that oppose the acutely beneficial effects of NF-kappaB seen in the inflammatory response. Expression of NF-kappaB with age is consistent with elevated levels of inflammatory markers and a pro-inflammatory phenotype, manifested in many age-associated diseases. While inducible activating mechanisms for NF-kappaB in the innate immune response are well characterized, constitutive activation in aging cells warrants further investigation of mechanisms collectively called atypical pathways. In this review, we provide a comprehensive examination of such NF-kappaB activating mechanisms, including mitochondrial dysfunction, endoplasmic stress response, organelle cross-talk, secondary messengers and DNA damage. Investigation of mechanisms of NF-kappaB in aging as an important marker of cellular stress provides guidance for the development of a systems view of cellular aging.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19174186     DOI: 10.1016/j.exger.2008.12.005

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  29 in total

Review 1.  Role of TRP ion channels in cancer and tumorigenesis.

Authors:  George Shapovalov; Abigael Ritaine; Roman Skryma; Natalia Prevarskaya
Journal:  Semin Immunopathol       Date:  2016-02-03       Impact factor: 9.623

2.  The Regulation of Aging and Longevity: A New and Complex Role of p53.

Authors:  Zhaohui Feng; Meihua Lin; Rui Wu
Journal:  Genes Cancer       Date:  2011-04

3.  Characteristics of lymphocyte nuclear factor-κB signal transduction kinase expression in aging process and regulatory effect of epimedium flavonoids.

Authors:  Xiao-yu Liu; Qi Wang; Shi-jin Xia; Jian-hua Huang; Zi-yin Shen; Hao Xu
Journal:  Chin J Integr Med       Date:  2011-09-11       Impact factor: 1.978

Review 4.  Comparing the yeast retrograde response and NF-κB stress responses: implications for aging.

Authors:  Visish Srinivasan; Andres Kriete; Ahmet Sacan; S Michal Jazwinski
Journal:  Aging Cell       Date:  2010-10-21       Impact factor: 9.304

Review 5.  Hypothalamic inflammation: a double-edged sword to nutritional diseases.

Authors:  Dongsheng Cai; Tiewen Liu
Journal:  Ann N Y Acad Sci       Date:  2011-12       Impact factor: 5.691

6.  Proteasome inhibition up-regulates inflammatory gene transcription induced by an atypical pathway of NF-kappaB activation.

Authors:  Sarah J Cullen; Subramaniam Ponnappan; Usha Ponnappan
Journal:  Biochem Pharmacol       Date:  2009-10-14       Impact factor: 5.858

7.  Poly(ADP-ribose) polymerase 1 at the crossroad of metabolic stress and inflammation in aging.

Authors:  Matthias Altmeyer; Michael O Hottiger
Journal:  Aging (Albany NY)       Date:  2009-05-20       Impact factor: 5.682

8.  Rule-based cell systems model of aging using feedback loop motifs mediated by stress responses.

Authors:  Andres Kriete; William J Bosl; Glenn Booker
Journal:  PLoS Comput Biol       Date:  2010-06-17       Impact factor: 4.475

9.  Chronic NF-kappaB activation delays RasV12-induced premature senescence of human fibroblasts by suppressing the DNA damage checkpoint response.

Authors:  Christina Batsi; Soultana Markopoulou; George Vartholomatos; Ioannis Georgiou; Panagiotis Kanavaros; Vassilis G Gorgoulis; Kenneth B Marcu; Evangelos Kolettas
Journal:  Mech Ageing Dev       Date:  2009-05-03       Impact factor: 5.432

10.  Alterations in transcriptional responses associated with vascular aging.

Authors:  Yumei Zhan; Lei Yuan; Peter Oettgen
Journal:  J Inflamm (Lond)       Date:  2009-05-21       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.